David Frank, who lost his mother to a severe form of steatotic liver disease and has since become a…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
April is officially recognized in the U.S. as National Donate Life Month, an opportunity to highlight the extraordinary impact of…
CHOLESTASIS
NewsInflammation markers may predict fetal risk in ICP: Study
Blood levels of certain pro-inflammatory proteins are elevated in people with intrahepatic cholestasis of pregnancy (ICP), and these inflammatory…
An artificial intelligence (AI) tool that analyzes patterns in blood molecules may help distinguish people with primary sclerosing cholangitis…
FATTY LIVER DISEASE
NewsTrial of WVE-007 for obesity aims to inform decisions about drug for MASH
An upcoming portion of an ongoing clinical trial that will test Wave Life Sciences’ WVE-007 in adults with obesity…
BILIARY ATRESIA
NewsMost babies with biliary atresia test positive for rotavirus antibodies
Most infants with the rare liver disease biliary atresia (BA) show signs of a previous rotavirus infection, suggesting the…
Mirum Pharmaceuticals is making progress with a quartet of late-stage clinical trials designed to test brelovitug, the company’s experimental…
CHOLANGITIS
NewsStudy indicates which PBC patients may see liver function recovery
Primary biliary cholangitis (PBC) patients who have irreversible liver scarring that affects the organ’s function are more likely to…
FATTY LIVER DISEASE
NewsHK2 protein identified as potential treatment target for MASH: Study
Two proteins called S100A11 and HK2 contribute to the abnormal buildup of fat in the liver that characterizes steatotic…
Backed by millions in U.S. funding, scientists from Johns Hopkins Medicine in Baltimore will be leading a new international consortium…